Jens F. Poschet, PhD, PMP

505-553-0675 (Cell)                    301-304-5290(Home)           E-mail:  jfposchet@yahoo.com

 

TECHNICAL PROGRAM/PROJECT MANAGER

PMP^®-certified (Certification No 1448936) program manager of scientific, assay and platform development projects. Strong interpersonal skills and able to establish rapport and credibility with diverse groups ranging from scientists, clinicians, engineers, bioinformatics and IT experts to contract officers. Versed in government contracting and subcontracting and able to achieve optimal performance and value.  Expert user of Microsoft Office Suite (Word, Excel, PowerPoint, Vizio and Microsoft Project) multilingual (English, German and French) with a diverse background and knowledge of different cultural aspects. Holder of a Public Trust Clearance.

 

PROFESSIONAL EXPERIENCE

Peptineo, Albuquerque, NM (working from home office at New Market, MD)     03/2015 – current

Director Program Management

Program Management vaccine development, project submission value at $100M.

·   Supporting project submissions to Broad Agency Announcements (BAA) of Biomedical Advanced Research and Development Authority (BARDA) for Ebola vaccine and antibiotic development.

 

The Geneva Foundation, Frederick, MD         05/2015 – 03/2016

Senior Scientist

Assistant Portfolio Manager of USAMRMC traumatic brain injury (TBI) portfolio covering pre-clinical, clinical trials, technology development, pharmacological treatments, nanotechnology and IT projects/databases.

·   Analyzed portfolio of over 600 Neurotrauma projects of $1B (2001 to present) Department of Defense (DoD) investment and developed methodologies to categorized and track open/closed projects, advanced development projects, TBI severity, project type (clinical, pre-clinical and technology development).

·   Submitted monthly Neurotrauma Report to the Office of the Surgeon General.

·   Developed Request for Information or Proposal (RFI/RFP) as well as MOU for Army partners.

·   Access Committee Member Fed. Interagency TBI Research (FITBIR) Informatics System.

 

Leidos Biomedical Research Inc., FNLCR, Frederick, MD       11/2011 – 04/2015

Technical Project Manager II

Managed National Cancer Institute (NCI), the Center for Strategic Scientific Initiatives and Directorate of Cancer Biology initiated projects. $4M worth of projects delivered on time and budget.

·  Wrote and published Statements of Work (SOW) to solicit NCI oncology RFPs dealing with genomic, proteomic, physical science, biospecimen and bioinformatics/IT development projects.

·  Chaired Source Evaluation Groups (SEG) setting evaluation criteria to assess technical responses, project management plan, timelines (schedule), budgeting and risk of submitted proposals.

·  Negotiated government lead contracts between, Leidos contract/financial offices, and the subcontractors performing work. Familiar with government FAR-clauses.

·  Managed cost, schedules, quality of deliverables and milestones, through documentation of project progress using data bases and development of risk management strategies and change management.

·  Executed complex simultaneous projects following PMP best practices, including site visits to ensure performance and project adhered to standard operating protocols (SOP).

·  Maintained familiarity with latest scientific trends and technologies acting as Subject Matter Expert (SME) to support customer relationship management and the development of new projects.

·  Prepared and presented monthly reports to NCI and Leidos senior management and held regular meetings consulting with government customers, contributing to the strategic planning of the program.

 

Sapient Government Services, Washington, DC     7/2010 – 11/2011

Senior Manager

Program coordination and management at National Cancer Institute’s (NCI) Center for Biomedical Informatics and Information Technology’s (CBIIT).

·  Stakeholder Management for requirements gathering on Electronic Health Record (EHR) project.

·  Subject Matter Expert and liaison on scientific international outreach projects of NCI developing IT tools. Improved international interactions between software developers and scientific and medical specialists.

·  Developed and implemented scientific impact reviews (gap analysis) of bioinformatics projects to integrate the needs of the scientific and clinical community with the bioinformatics and IT community.

·  Prepared reports to Sapient upper management and directorate of CBIIT.

 

BAE SYSTEMS, Inc. Electronic Solutions & Intelligence, Washington, DC      7/2009 – 5/2010

Program Manager II, Advance Materials Group

Managed and developed multimillion-dollar programs as capture lead for DoD subcontracts and project submissions. $9M program and submissions were on time and cost.

·   Obtaining phase 2 funding for DARPA/STO ($4M plus an additional $1M cost) Hyperadsorptive Atmospheric Sampling Technology (HAST) platform. Project controlled through staffing, budgeting and timeline control (EVM), and risk management. Cross matrixed, multi-location effort with over 30 personal.

·  Customer relationship management through regular meetings with DoD clients marketing new business opportunities and potential projects.

·  Main liaison for interactions between the administrative units of DARPA, DoD and BAE Systems, such as finance, legal and contracts offices, ensuring that projects were delivered on cost and time.

·  Capture lead for DoD proposals, created work breakdown structure (WBS), schedule, cost, project management plans (PMP), wrote technical/scientific responses, and submitted projects.

·   Programs: 7-Day Biodefense (DARPA BAA 09-43), Bioinspired Photonics (DARPA BAA 09-71), Limit of Thermodynamic Storage (LOTS) of energy (DARPA BAA-10-15), Bold Quest 11 Fires on Dismounts Combat ID (Army Contracting Command). (Total Value $25M)

·  Presented monthly progress reports to DARPA and senior management at BAE Systems.

 

LUNA INNOVATIONS, Danville, VA         2/2009 -7/2009

Senior Research Scientist, Luna nanoWorks

Lead scientist and program/project development, localized fullerenes to organelles using life cell microscopy.

·  Investigated the effects of trimetasphere fullerenes and other nanoparticles on cellular location and therapeutic potential in brain cancer cell lines.

·  Designed and executed all imaging studies and presented monthly reports to Luna Leadership.

 

SANDIA NATIONAL LABORATORIES, Biomol. Analysis & Imaging, Albuquerque, NM         5/2006 – 1/2009

Staff Scientist, Research Associate Professor at the University of New Mexico, Department of Biology

Principle Investigator, Project development, Mentor and Supervisor.  Published reports and papers, submitted project applications to NIH, DTRA and DARPA.  100% of project delivered on time and cost

·  Coordinated the biological, engineering and bioinformatics efforts to develop a microfluidic platform to quantify signaling events in macrophages in response toxin challenges from  biological threat agents.

·  Designed scientific studies/experiments, authored and executed all standard operating protocols (SOP).

·  Led drug discovery using small molecule therapies directed against bacterial and viral infections and studied toxicology of nanoparticles on immune, lung and small intestinal cells.

·  Steering committee member of the International Council On Nanotechnology (ICON) guiding the development and principles of nanotechnology development and science on an international level.

·  Prepared report to Department of Homeland Security on “Dangerous Biological Agents: An Assessment of Acquisition Strategies and Uncertainties”.

·  Maintained up to date knowledge of latest scientific developments in the field of biological threat agents.

·  Prepared and presented progress reports to senior Sandia leadership and Project Steering Committee, as well as presentation of data at international conferences.

 

UNIVERSITY OF NEW MEXICO, Molecular Genetics and Microbiology, Albuquerque, NM      8/2001-5/2006

Assistant Professor LAT.

Research lead, project development, mentor and staff supervisor. Co-PI on $0.8M project. Submitted grant applications to NIH and private foundations. 100% successful completion of all projects.

·  Developed imaging and immunological assays to detect intracellular signaling events in Cystic Fibrosis (CF) lung cells, such as intracellular acidification along the endosomal and trans-Golgi network path.

·  Drug discovery of small molecular treatments to correct observed defects in CF lung epithelial cells and reduce bacterial infection of CF cells and increase wound healing and the kinetics of recovery.

·  Presented data at international meetings and published papers in internationally recognized journals, leading to clinical trials and NIH press release.

 

UNIVERSITY OF MICHIGAN, Dept. of Microbiology and Immunology, Ann Arbor, MI            8/1999-8/2001

Postdoctoral Fellow and Research Associate II

Project development, staff supervision, presenting and publishing data.  

·   Assay development for immunological assays (ELISA, Western Blotting) and life cell microscopy.

·   Studied acidification and vesicular trafficking in CF lung epithelial cells using life cell and immuno-fluorescence microscopy. All projects transferred to University of New Mexico.

 

UNIVERSITY OF LONDON, Queen Mary College, DDRC, London, UK                 9/1995-7/1999

Post-Doctoral Fellow

Lab manager, mentor to MS students, presenting and publishing data. $500K project delivered on time/cost.

·     Led drug discovery (proteases and lectins) to prevent S. typhimurium invasion of small intestinal cell lines and macrophages.

 

Academic Surgical Unit, St. Mary’s Medical School, Imperial College of Science, Technologies and Medicine, University of London, Centocor plc, Malvern, PA,USA. London, England                        7/1991-7/1992

Laboratory Technician

·   Developed an ELISA method to measure administered chimeric monoclonal antibodies directed against colorectal cancer cells and the resulting anti-idiotype antibodies.

 

Ciba-Geigy AG, Dept. of Oncology and Virology, Basel, Switzerland.        6/1984-9/1989

Apprenticeship Laboratory Technician

·   Experience gained in: animal handling and general laboratory techniques.

·   Developed an E. coli expression system for purification and kinetic characterization of protein kinases.

·   Designed and executed phosphorylation assay. This work was part of the development of Glevec.

 

EDUCATION

UNIVERSITY OF LONDON, UK. St Bartholomew’s Hospital, Queen Mary College. London, UK

Ph.D. awarded in Gastroenterology/Pharmacology. Funded by Medical Research Council (MRC) Grant.
Title:  Small Intestinal Membrane Transport of Penicillin.

 

UNIVERSITY OF MANCHESTER, UK.

B.Sc. (Hons) Class 2.1 in Biochemistry
B.Sc. (Hons) Thesis: Isolation and Purification of a 150K Glycoprotein of the Extracellular Matrix.

FELLOWSHIPS AND APPOINTMENTS

·               Research Associate Professor, University of New Mexico (UNM), Albuquerque, NM, Dept. of Biology

·               Assistant Professor, LAT at UNM, Albuquerque, NM, Dept. of Molecular Genetics and Microbiology

·               Cystic Fibrosis Foundation (USA) Fellowship

·               Joint Research Board (UK) Postdoctoral Fellowship

·               Medical Research Council (UK) Graduate Student Fellowship

 

PROFESSIONAL SOCIETIES AND COMMITTEES

·               Project Manager Professional (PMP) certified through the Project Management Institute. (Current)

·               Member of the American Society of Cell Biology (ASCB)

·               Member of Steering Committee of International Council on Nanotechnology (ICON) (2007-2010)

·               Member Board of Directors New Mexico Biotechnology and Biomedical Association (NMBio) (2008-2009)

·               2006 and 2007 Recipient of USA President’s Volunteer Service Award (Freedom Corps)

1